Article Details
Retrieved on: 2017-12-12 18:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Intellia Therapeutics (NASDAQ: NTLA) said that John Leonard, currently the company's executive vice president of research and development, will become its president and CEO, effective Jan. 1. Leonard will step in for founding CEO Nessan Bermingham, who is returning to the venture capital industry, ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here